12 research outputs found
Medial patellofemoral ligament anatomy: is it a predisposing factor for lateral patellar dislocation?
convertibleCARs: A chimeric antigen receptor system for flexible control of activity and antigen targeting
Mass spectrometry-based identification of bacteria isolated from industrially contaminated site in Salamanca (Mexico) and evaluation of their potential for DDT degradation
Dysfunctional inhibitory control in Parkinson’s disease patients with levodopa-induced dyskinesias
Health care for older people in Italy: The U.L.I.S.S.E. Project (Un link informatico sui servizi sanitari esistenti per l'anziano - a computerized network on health care services for older people).
Objectives: The U.L.I.S.S.E. study is aimed at describing older patients who are cared for in hospitals,
home care or nursing homes in Italy. Design: The U.L.I.S.S.E. study is an observational multicenter prospective
1-year study. Setting: Overall, 23 acute geriatric or internal medicine hospital units, 11 home care services and 31
nursing homes participated in the study. Measurements: The patient\u2019s evaluation was performed using
comprehensive geriatric assessment instruments, i.e. the interRAI Minimum Data Set, while data on service
characteristics were recorded using ad-hoc designed questionnaires. Results: The older subjects who are in need
of acute and long term care in Italy have similar characteristics: their mean age is higher than 80 years, they have
a high level of disability in ADL, an important multimorbidity, and are treated with several drugs. The prevalence
of cognitive impairment is particularly high in nursing homes, where almost 70% of residents suffer from it and
40% have severe cognitive impairment. On the other hand, there is a shortage of health care services, which are
heterogeneous and fragmented. Conclusions: Health care services for older people in Italy are currently
inadequate to manage the complexity of the older patients. An important effort should be undertaken to create a
more integrated health care system
Health care for older people in Italy: The U.L.I.S.S.E. Project (Un link informatico sui servizi sanitari esistenti per l'anziano - a computerized network on health care services for older people)
Objectives: The U.L.I.S.S.E. study is aimed at describing older patients who are cared for in hospitals,
home care or nursing homes in Italy. Design: The U.L.I.S.S.E. study is an observational multicenter prospective
1-year study. Setting: Overall, 23 acute geriatric or internal medicine hospital units, 11 home care services and 31
nursing homes participated in the study. Measurements: The patient\u2019s evaluation was performed using
comprehensive geriatric assessment instruments, i.e. the interRAI Minimum Data Set, while data on service
characteristics were recorded using ad-hoc designed questionnaires. Results: The older subjects who are in need
of acute and long term care in Italy have similar characteristics: their mean age is higher than 80 years, they have
a high level of disability in ADL, an important multimorbidity, and are treated with several drugs. The prevalence
of cognitive impairment is particularly high in nursing homes, where almost 70% of residents suffer from it and
40% have severe cognitive impairment. On the other hand, there is a shortage of health care services, which are
heterogeneous and fragmented. Conclusions: Health care services for older people in Italy are currently
inadequate to manage the complexity of the older patients. An important effort should be undertaken to create a
more integrated health care system
Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters
There is increasing evidence that the biochemical and cellular phenomena induced by blood/membrane/dialysate interactions contribute to dialysis-related intradialytic and long-term complications. However, there is a lack of large, prospective, randomized trials comparing biocompatible and bioincompatible membranes, and convective and diffusive treatment modalities. The primary aim of this prospective, randomized trial was to evaluate whether the use of polysulfone membrane with bicarbonate dialysate offers any advantages (in terms of treatment tolerance, nutritional parameters and pre-treatment beta(2)-microglobulin levels) over a traditional membrane (Cu-prophan(R)). A secondary aim was to assess whether the use of more sophisticated methods consisting of a biocompatible synthetic membrane with different hydraulic permeability at different ultrafiltration rate (high-flux hemodialysis and hemodiafiltration) offers any further advantages. Seventy-one Centers were involved and stratified according to the availability of only the first two or all four of the following techniques: Cuprophan(R) hemodialysis (Cu-HD), low flux polysulfone hemodialysis (LfPS-HD), high-flux polysulfone high-flux hemodialysis (HfPS-HD), and high-flux polysulfone hemodiafiltration (HfPS-HDF). The 380 eligible patients were randomized to one of the two or four treatments (132 to Cu-HD, 147 to LfPS-HD, 51 to HfPS-HD and 50 to HfPS-HDF). The follow-up was 24 months. No statistical difference was observed in the algebraic sum of the end points between bicarbonate dialysis with Cuprophan(R) or with low-flux polysulfone, or among the four dialysis methods under evaluation. There was a significant decrease in pre-dialysis plasma beta(2)-microglobulin levels in high-flux dialysis of 9.04+/-10.46 mg/liter (23%) and in hemodiafiltration of 6.35+/-12.28 mg/liter (16%), both using high-flux polysulfone membrane in comparison with Cuprophan(R) and low-flux polysulfone membranes (P=0.032). The significant decrease in pre-dialysis plasma beta(2)-microglobulin levels could have a clinical impact when one considers that beta(2)-microglobulin accumulation and amyloidosis are important long-term dialysis-related complications
Navigating CAR-T cells through the solid-tumour microenvironment
The adoptive transfer of T cells that are engineered to express chimeric antigen receptors (CARs) has shown remarkable success in treating B cell malignancies but only limited efficacy against other cancer types, especially solid tumours. Compared with haematological diseases, solid tumours present a unique set of challenges, including a lack of robustly expressed, tumour-exclusive antigen targets as well as highly immunosuppressive and metabolically challenging tumour microenvironments that limit treatment safety and efficacy. Here, we review protein- and cell-engineering strategies that seek to overcome these obstacles and produce next-generation T cells with enhanced tumour specificity and sustained effector function for the treatment of solid malignancies